Xtant Medical
Manufacturing · Montana, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
664 Cruiser Ln, Belgrade, Montana, 59714...Phone Number
(406) 388-0480Website
www.xtantmedical.comRevenue
$117.3 MillionStock Symbol
XTNTIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Xtant Medical
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers. The symbols and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries.Explore more
Xtant Medical Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Xtant Medical your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Xtant Medical is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Xtant Medical launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Xtant Medical
Check if Xtant Medical has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Xtant Medical recently announced quarterly report
Funding: Get notified immidiatlly once Xtant Medical has new funding data
Click to see if Xtant Medical had a recent Job posting/layoffs
Xtant Medical, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Xtant Medical
Find 3 more new buyers
Compare Similar Companies to Xtant Medical
Compare insights from companies similar to Xtant Medical, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Xtant Medical is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Xtant Medical is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Xtant Medical.
Xtant Medical financials insights
Gather financial insights about Xtant Medical, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$20M
2022
Share Placement
$9.7M
Xtant Medical Tech Stack
A closer look at the technologies used by Xtant Medical
See more technologies
Most Recent Scoops
Project
Xtant Medical has announced the commercial launch of Trivium Shaped, an extension of its Trivium bone graft portfolio featuring pre-shaped configurations including boats and strips designed to enhance consistency and handling across a range of surgical applications, building on the Trivium Sculptable format launched in April 2025.
Earnings
Xtant Medical has reported a gross margin of 57.3% for Q1 2026, compared to 61.5% for Q1 2025, with the decrease primarily attributable to the cessation of Q-Code license revenue from amniotic membrane agreements that terminated at the end of 2025, partly offset by improvements in product mix.
Earnings, Finance
Earnings
Xtant Medical has reported cash and cash equivalents of $12.2 million, total indebtedness of $12.2 million, and revolving credit facility availability of $11.8 million as of March 31, 2026, compared to $17.3 million in cash, $25.4 million in total indebtedness, and $3.8 million in revolving credit availability as of December 31, 2025.
Earnings, Accounting, Financial Reporting, Finance
Earnings
Xtant Medical has reported a net loss of $3.1 million, or $0.02 per basic and diluted share, for Q1 2026, compared to net income of $58,000, or breakeven per share, for Q1 2025.
Earnings, Finance
Earnings
Earnings, Finance
Xtant Medical News & Media
Xtant Medical Hldgs Q1 2026 Earnings Call Transcript
Xtant Medical Hldgs (AMEX:XTNT) released first-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. The full earnings call is available at https://www.webcaster5.com/Webcast/Page/3039/53872 Summary Xtant Medical Holdings Inc reported first quarter 2026 revenue of $20.9 million, a decrease from the previous yXtant Medical Reports First Quarter 2026 Financial Results
Raises full-year 2026 revenue guidance to a range of $101-$105 million Significantly strengthens balance sheet Enters into exclusive U.S. distribution agreement for Dilon Technologies' HEMOBLAST® Bellows product for high-performance hemostasis; hires Dilon's U.S. sales team BELGRADE, Mont....Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026
BELGRADE, Mont., May 7, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a medical technology company focused on surgical solutions for spinal and other orthopedic conditions, today announced that it will release its financial results for the first quarter ended...Xtant Medical and Dilon Technologies Announce Exclusive U.S. Distribution Agreement for Dilon's HEMOBLAST® Bellows Product
Xtant has hired Dilon's U.S. sales team to assist in selling the HEMOBLAST® Bellows product and penetrating the estimated $2.0 billion global addressable market for hemostatic products BELGRADE, Mont. and NEWPORT NEWS, Va., April 13, 2026 /PRNewswire/ -- Xtant Medical Holdings, Inc. (NYSE...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Xtant Medical
Sign Up For FreeTo access detailed company insights
Xtant Medical Holdings, Inc. (www.xtantmedical.com) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, o... Read More
